Tamibarotene

CAS No. 94497-51-5

Tamibarotene( Amnolake | NSC 608000 | Retinobenzoic Acid | Tamibarotene )

Catalog No. M16769 CAS No. 94497-51-5

Tamibarotene is a synthetic retinoic acid receptor (RAR) agonist with high specificity for RARα and RARβ over RARγ.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 37 In Stock
10MG 37 In Stock
25MG 55 In Stock
50MG 67 In Stock
100MG 91 In Stock
200MG 144 In Stock
500MG 244 In Stock
1G 362 In Stock

Biological Information

  • Product Name
    Tamibarotene
  • Note
    Research use only, not for human use.
  • Brief Description
    Tamibarotene is a synthetic retinoic acid receptor (RAR) agonist with high specificity for RARα and RARβ over RARγ.
  • Description
    Tamibarotene is a synthetic retinoic acid receptor (RAR) agonist with high specificity for RARα and RARβ over RARγ.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Amnolake | NSC 608000 | Retinobenzoic Acid | Tamibarotene
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    Retinoid Receptor
  • Recptor
    RARα| RARβ
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    94497-51-5
  • Formula Weight
    351.44
  • Molecular Formula
    C22H25NO3
  • Purity
    >98% (HPLC)
  • Solubility
    Ethanol: 70 mg/mL (199.18 mM); DMSO: 70 mg/mL (199.18 mM)
  • SMILES
    O=C(O)C1=CC=C(C(NC2=CC=C3C(C)(C)CCC(C)(C)C3=C2)=O)C=C1
  • Chemical Name
    4-[(5,5,8,8-Tetramethyl-6,7-dihydronaphthalen-2-yl)carbamoyl]benzoic acid

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Sanda T, et al. Leukemia, 2005, 19(6), 901-909.
molnova catalog
related products
  • CD 1530

    CD 1530 is a selective and potent RARγ agonist (Kd:150 nM) with potential anticancer activity, shows insecticidal activity against Cryptobacterium hidradii nematodes, and can be used to study oral carcinogenesis.

  • K-8012

    K-8012 is a modulator of the N-terminally truncated RXRα and improves anticancer activities in an RXRα-dependent manner.

  • Fluorobexarotene

    Fluorobexarotene possesses an apparent RXR binding affinity that is 75% greater than Bexarotene.?